Connect with us
An international team combining advanced NMR and AI has developed the SHARPER NMR technique, accelerating drug discovery tenfold. Published in the Journal of the American Chemical...
Novo Nordisk raised its bid for Metsera to €8.677 billion—11% higher than before—after Pfizer accused it of anti-competitive tactics. Metsera’s board deemed Novo’s offer a “Superior...
Pulmonary arterial hypertension (PAH) is a rare, disabling disease with complex diagnosis. MSD introduced sotatercept, Europe’s first activin signaling inhibitor for PAH, improving vascular balance and...
AI-driven multimodal diagnostics can predict heart attack risk up to 10 years before symptoms by integrating medical imaging, lab tests, and health records to assess biological...
Novartis will acquire U.S.-based Avidity Biosciences for $12 billion, expanding into advanced RNA-based therapies. The $72-per-share tender offer, a 46% premium, was unanimously approved. Avidity will...
At ESMO 2025, new data marked a major advance in breast cancer treatment. ADCs like trastuzumab deruxtecan and datopotamab deruxtecan significantly improved survival and reduced relapse...
Novo Nordisk Chairman Helge Lund, Vice Chairman Henrik Poulsen, and five independent directors resigned after disagreements with the Novo Nordisk Foundation, its majority shareholder. The Foundation...
Vytrus Biotech, whose stock has surged nearly 200% in 2025, will open a new production plant in Catalonia to support expansion and meet rising demand. Targeting...
The AstraZeneca Foundation awarded €1 million in its 9th Young Researchers Awards to support four Spanish scientific teams in fields like diabetes, oncology, and respiratory diseases....
A University of Barcelona study introduces a dual strategy for brain repair by combining stem cell therapy with sustained BDNF delivery. Using genetically modified human neural...